Discordant HER2/Neu Status of Breast Cancer.

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

NCT03568448 ·Status: ACTIVE_NOT_RECRUITING

Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer

NCT06738459 ·Status: RECRUITING

99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy

NCT05695859 ·Status: COMPLETED

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

NCT06149377 ·Status: COMPLETED

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

NCT02992769 ·Status: UNKNOWN

68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

NCT06559371 ·Status: RECRUITING

The Memorial Sloan-Kettering Cancer Center (MSKCC

NCT01509963 ·Status: COMPLETED

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.

NCT05203497 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients

NCT05365191 ·Status: UNKNOWN ·Phase: NA

99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes

NCT05412446 ·Status: COMPLETED ·Phase: PHASE2

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

NCT00001496 ·Status: COMPLETED

Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil

NCT05034393 ·Status: COMPLETED

Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer

NCT05307757 ·Status: RECRUITING

A Study of Patients With HER2-Positive Metastatic Breast Cancer

NCT00105456 ·Status: COMPLETED

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT03381092 ·Status: UNKNOWN

Establishment and Clinical Application of Precise SLNB System in Breast Cancer: a Randomized, Multicenter, Controlled Study

NCT03857932 ·Status: RECRUITING ·Phase: NA

Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics

NCT05826197 ·Status: UNKNOWN

HER2-positive Breast Cancer Registry

NCT06603597 ·Status: RECRUITING

99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy

NCT05412459 ·Status: COMPLETED

Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates

NCT05961280 ·Status: COMPLETED

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

NCT01514565 ·Status: UNKNOWN

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

NCT06833502 ·Status: RECRUITING ·Phase: PHASE2

Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer

NCT01597999 ·Status: UNKNOWN ·Phase: PHASE4

Whole-body MRI for the Detection of Metastasis

NCT02183597 ·Status: WITHDRAWN

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

NCT06261918 ·Status: RECRUITING